Results 1 to 10 of 78
How to Boost Your Returns With ONE Secret ETF Strategy
"How to Boost Your Returns With ONE Secret ETF Strategy"
Free Webinar Recorded on Tuesday, December 3rd at 8:00 PM EST (New York Time)
In this free online class John Carter will share with you:
A Powerful Simple Strategy for Trading Options on ETFs
The SAFE Levels to Take Risk
The Very Best ETFs to use
Which ETFs You Have to Avoid Like the Plague
And much more...
Don't miss this free trading education from a real pro!
There are 9 reasons why you SHOULD trade options on ETFs... and they're in this video
There are 9 reasons why you SHOULD trade options on ETFs...and they're in this video...
9 Reasons to trade Options on ETFs
You'll learn from John Carter...
Why ETFs are his BEST Instrument for Options Trading
How he wires 34k from his Trading, to his Personal Account
Why ETF Options are untouchable by Market Makers
And a LOT more...
Video shows legendary 223k profit day in the market
Proof that 'account size doesn't matter' is often very hard to find. People say it doesn't matter...but can't prove it.
This video PROVES it
Legendary trader John Carter had a pretty good day recently... where he recorded live his 223k trading day! This was recorded in his REAL money accounts...
97k on Apple
93k on Google
104k on Priceline
Just Released: 50 top movers in 2013
Just Released: 50 top movers in 2013
MarketClub.com has been in the business of trend following for decades, and they are happy to announce that you can take a look at Today's Top 50 Trending Stocks now...for free! This dynamic report is a list of market movers that can make a difference in your portfolio for 2013.
It costs you nothing, and it could be the game changer you have been looking for.
It's time you started trading like the smart money, get started today for free!
Just go here to access your list of top 50 trending stocks!
Join our stock picking contest
See how your picks stack up against other posters - join our weekly stock picking contest. Your win will be registered under your username and everyone will know about your stock picking talents.
Just go here to read the rules and post your pick.
LFVN - Lifevantage
For the medium term
TZYM- Gap Down Trade
I wanted to share with you a nice trade I made today on TZYM, this stock is an example of a best-case scenario gap down play. Before market open my scans showed large activity on TZYM, I mentioned it as a possible play in chat.
At market open there was a confirmation of large volume and very clean upward trend. I was filled at 1.86 and watched the stock consolidate at 2, then rip all the way up to 2.9, consolidate some more and rip to 3.1. I held on until I eventually sold at 2.94 for a return of 59%. Overall it was a good day
CIS is gonna BLOW UP like SCEI if it breaks
Looking for a breakout above the 2.48 level ( 50 dma ). Short term price target after the break is 3. The stock starts showing ?buy' signals again, closing today above its 20-day moving average, which is a very bullish sign. Although the stock didn't perform well last year, we start to see now some signals of rebound. Additionally, the chart shows a MACD crossover, a bullish sign. Long-term investors may hold with a stop at $2.
Default SIFY ?
As you can see, I am pretty new to all of this. Trying to learn what everyone is looking at, and seeing in indicators, and what means what. So I have been trading for a couple of years on a short term (weekly-monthly) basis, based strickly off financials. I have just recenlty been looking into trends and indicators and I think i may have seen this stock on here once. So I kept watchin it cause at least I could see that it keeps dropping to about 4 and bouncing every two weeks with no news. Any thoughts on this one? what should I be looking at here?
(hope my URL pic works)
MAXY - Seeking Alpha Biotech pick.
Maxygen: A Biotech Play With Low Downside - Part 1
In the biotech sector, it's rare to find a stock that doesn't feature clinical risk, provides cash-supported downside protection, has attractive drug optionality and a management team with a track record of returning value to shareholders.
We think Maxygen (MAXY) is one such stock that deserves to be examined by most investors.
We have split our analysis into two articles. This first part discusses Maxygen's history, the company's current drivers and the contingent payment it may receive from Bayer Healthcare (BAYRY.PK). In our second part, we examine the company's G34 drug, our valuation estimates based on a downside, base and upside scenario, and our conclusion.
